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The role of the local renin–angiotensinsystem (RAS) has been extensively stu-
died in the progression of kidney disease.
Previous research has indicated that local
tissue production of angiotensin II (Ang II),
which functions in an intracrine, autocrine
and paracrine manner, is important in the
progression of kidney disease. Clinical and
animal studies have shown that treatment
with angiotensin-converting enzyme inhibi-
tors and Ang II type 1 receptor blockers
reduces the progression of diabetic nephro-
pathy, thereby resulting in effective ameliora-
tion of proteinuria and glomerular damage.
However, these benefits cannot be fully
explained only by the hemodynamic effects
of the system causing a reduction in blood
pressure.1,2
In addition to the well-characterized sys-
temic RAS, the presence of a local intrarenal
RAS has now been generally accepted. The
mRNA and functional proteins of the RAS,
including angiotensinogen (AGT), renin, pro-
renin receptor,3 angiotensin I-converting
enzyme and Ang II receptors (AT-1 and AT-2
subtypes), are expressed in rat mesangial
cells,4,5 mouse and rat immortalized renal
proximal tubular cells6,7 and rat collecting
duct cells8,9 (Table 1).
Vidotti et al.4 described a significant
increase in Ang II generation in mesangial
cells exposed to a high glucose concentration,
suggesting that the mechanisms responsible
for this enhancement primarily include an
increase in intracellular renin activity paral-
leled by an increase in AGT gene expres-
sion. These increases indicate the availability
of the substrate to renin. Interestingly, the
increased expression of intrarenal AGT has
been shown to be directly involved in disease
progression in several animal models of renal
injury.10,11
Brezniceanu et al.12 demonstrated that
tumor growth factor-b1 stimulates Ang gene
expression in rat kidney proximal tubular
cells and that its action is mediated, at least
in part, by reactive oxygen species (ROS)
generation, p38 MAPK activation and p53
expression. These results suggest that Ang II
and tumor growth factor-b1 form a positive
feedback loop to enhance their respective
gene expression, leading to renal injury.
Although the signal transduction pathways
involved in AGT expression have been
described by several authors, the mechanism
has not been completely elucidated.13,14
In this issue of Hypertension Research,
Ohashi et al.15 demonstrated that the levels
of glomerular AGT expression in Zucker
diabetic fatty (ZDF) obese rats were higher
than the levels in ZDF lean rats. In addition,
they reported increased levels of immuno-
reactivity for 4-hydroxy-2-nonenal, urinary
excretion of 8-isoprostane and markers of
ROS in the ZDF obese animals. They also
focused on the signal transduction pathway
for glomerular AGT expression. H2O2
induced an increase in AGT expression in a
dose-dependent and time-dependent manner,
and the H2O2-induced upregulation of AGT
was suppressed by catalase. Moreover, the
H2O2-induced upregulation of AGT was
inhibited by a mitogen-activated protein
kinase (MAPK), a kinase inhibitor (MEK)
and a c-Jun amino-terminal kinase (JNK)
inhibitor, but was not inhibited by a p38
MAPK inhibitor.
Two aspects of their results were particu-
larly intriguing. First, they offered further
evidence for the pathological role of an acti-
vated AGT in mesangial cells found in ZDF
rats with diabetic nephropathy. Second, their
data demonstrated increased AGT expression
in mesangial cells mediated by H2O2 with
activation of extracellular-regulated kinase
(ERK)/JNK pathways, but not p38 MAPK
pathways. This result provides a new mecha-
nism for the activation of intrarenal RAS in
diabetic nephropathy. The increase of AGT
could result in high levels of Ang II in these
cells, which may result in intracrine actions
involved in the well-known effects of diabetic
nephropathy, such as induction of gene
expression (particularly genes involved in cell
growth and metabolism), synthesis of extra-
cellular matrix components, and manifesta-
tions that are typical of diabetic nephropathy.
ARE THERE CLINICAL IMPLICATIONS
FOR INCREASED INTRARENAL AGT?
AGT is the only known substrate for renin,
which is the rate-limiting enzyme of RAS.
The results described by Ohashi et al., in
addition to previous studies from Kobori’s
group that found elevated urinary AGT levels
in patients with chronic kidney disease
including patients with diabetes, confirm
that urinary AGT levels can function as an
Table 1 RAS along the nephron
Nephron Intrarenal RAS References
Mesangial cells ACE, AGT, AII, Ang 1–7, renin, renin pro-receptor, AT1 and AT2 3–5
Proximal tubule ACE, AGT, AII, Ang 1–7, renin, renin pro-receptor, AT1 6,7
Distal tubule AGT, AII 8
Collecting duct ACE, AGT, AII, Ang 1–7, renin, renin pro-receptor, AT1 8,9
Abbreviations: ACE, angiotensin I-converting enzyme; AGT, angiotensinogen; Ang II receptors; AT-1 and AT-2 subtypes;
RAS, rennin–angiotensin system.
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early biomarker for determining the status of
the intrarenal RAS.
These results strengthen the role of tissue
RAS acting in an autocrine, paracrine or
intracrine manner in local kidney control.
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